Erythromycin Lactobionate

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameErythromycin Lactobionate
Drug Alias NameEry-Toxinal dodecylsulfateBiomicronEromycinEriscelErythromycin 2'-propionate dodecyl sulfate (salt) +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1964/06/25
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesHospira
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHospira Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeD10AF02J01FA01S01AA17
Related LinksKEGG